Adverse effects of GH self administration on peripheral nerve. A case report.
To our knowledge there is no evidence of multientrapment neuropathy related to growth hormone (GH) administration. We observed the case of a 45-year-old bodybuilder complaining of paresthesias and dysesthesias of the hands and feet after self-administration of high-dose of recombinant GH therapy. The patient complained of transitory symptoms after each cycle of GH therapy. The electrodiagnosis showed: 1) moderate right carpal tunnel syndrome (CTS) and minimal left CTS; 2) mild right ulnar entrapment at elbow; 3) a reduction of motor nerve conduction velocity of the left ulnar nerve across elbow; 4) a reduction of the amplitude of the sensory nerve action potential of the left ulnar nerve in digit-wrist segment; 5) the absence of the ulnar F wave bilaterally registering from abductor digiti minimus. Our data suggest a multiple entrapment condition of the upper limbs; furthermore, based on the history (paresthesia at feet), we can hypothesize a mild involvement of distal sensory fibres in the legs (neurophysiologically negative). The anecdotal history and neurophysiological findings of this case suggest an increased awareness to the adverse effects of GH on peripheral nerve.
Caliandro
P
P
Unit of Neurology, Università Cattolica del Sacro Cuore, Rome, Italy. p.caliandro@rm.unicatt.it
Padua
L
L
Aprile
I
I
Conti
V
V
Pazzaglia
C
C
Pavone
A
A
Tonali
P
P
D002349:Carpal Tunnel Syndrome / Q000139:chemically induced*; D019382:Human Growth Hormone / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011115:Polyneuropathies / Q000139:chemically induced; D012646:Self Administration; D014459:Ulnar Nerve / Q000187:drug effects*; D017769:Ulnar Nerve Compression Syndromes / Q000139:chemically induced*; D014891:Weight Lifting
D019382:Human Growth Hormone